Jpmorgan Chase & CO Cryo Cell International Inc Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Cryo Cell International Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 11 shares of CCEL stock, worth $82. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11
Previous 11
-0.0%
Holding current value
$82
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CCEL
# of Institutions
15Shares Held
902KCall Options Held
0Put Options Held
0-
Hamilton Lane Advisors LLC410KShares$3.07 Million2.55% of portfolio
-
Sfi Advisors, LLC Montclair, NJ165KShares$1.24 Million0.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA115KShares$860,8420.0% of portfolio
-
Massmutual Trust CO Fsb111KShares$832,7620.02% of portfolio
-
Geode Capital Management, LLC Boston, MA23.7KShares$177,4270.0% of portfolio
About CRYO CELL INTERNATIONAL INC
- Ticker CCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 8,519,250
- Market Cap $63.9M
- Description
- Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...